Skip to main content

Table 2 Results representing the Cell cycle analysis of MFX and CFX treated MIA PaCa-2 cells

From: Moxifloxacin and ciprofloxacin induces S-phase arrest and augments apoptotic effects of cisplatin in human pancreatic cancer cells via ERK activation

24 h Sub G1 G1 S G2 48 h Sub G1 G1 S G2
MIA PaCa-2 MIA PaCa-2
0 μg/ml 5 ± 0.5 53.8 ± 3.2 7.5 ± 1 33.7 ± 2.1 0 μg/ml 2.6 ± 0.5 67.1 ± 3 6.3 ± 1.2 24 ± 1.5
MFX 100 μg/ml 5.7 ± 0.35 48.2 ± 2.1 10.4 ± 1.1 35.7 ± 3.1 MFX 100 μg/ml 2.1 ± 1.1 63.7 ± 2.5 10.6 ± 0.9 23.6 ± 1
MFX 200 μg/ml 6.2 ± 0.4 60.6 ± 4 11 ± 1.2 22.2 ± 2.3 MFX 200 μg/ml 3.5 ± 2 54.3 ± 2 18.1 ± 0.8 24.1 ± 0.5
MFX 400 μg/ml 28 ± 1.5 49.1 ± 2.6 7.1 ± 1.5 15.8 ± 1.8 MFX 400 μg/ml 37.6 ± 2.1 40 ± 3.4 11 ± 1.2 11.4 ± 1.8
CFX 100 μg/ml 4.5 ± 0.6 63 ± 1.5 8.9 ± 2 23.6 ± 1.8 CFX 100 μg/ml 5.5 ± 1.7 51.5 ± 1.5 14.3 ± 0.6 28.7 ± 3
CFX 200 μg/ml 18.5 ± 2 55.2 ± 2.1 9.1 ± 1.3 17.2 ± 2.3 CFX 200 μg/ml 28.4 ± 1.9 52.8 ± 2 14 ± 1.1 4.8 ± 4.5
CFX 400 μg/ml 30.1 ± 2 48.1 ± 3 7.3 ± 2 14.5 ± 2.7 CFX 400 μg/ml 59.9 ± 1.1 32.2 ± 3.9 4.4 ± 2 3.5 ± 3.2
  1. Values represent the percent of population in each phase. Values with significant changes have been highlighted with bold format